Literature DB >> 12909321

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload.

Oliver J Müller1, Mathias Lange, Henning Rattunde, Hans-Peter Lorenzen, Matthias Müller, Norbert Frey, Cordula Bittner, Warner Simonides, Hugo A Katus, Wolfgang M Franz.   

Abstract

OBJECTIVE: The activity of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is reduced in the failing myocardium. Therefore, transfer of SERCA2a cDNA is considered as a therapeutical approach. The aim of this study was analysis of the long-term effect of SERCA2a overexpression in normal as well as pressure overload challenged myocardium of transgenic rats.
METHODS: Independent transgenic rat lines were established expressing the rat SERCA2a cDNA specifically in the myocardium resulting in increased SERCA2a protein levels by 30-70%. Simultaneous measurements of isometric contraction and calcium transients were carried out in right ventricular papillary muscle preparations. Hemodynamic parameters were measured in hearts of unchallenged rats as well as 10 weeks after pressure overload induced by abdominal aortic banding.
RESULTS: Analysis of calcium handling and contractile parameters in isolated right ventricular papillary muscles revealed significant shortening of intracellular calcium transients and half maximal relaxation times (RT(50)). Assessing myocardial contractility in working heart preparations, both transgenic rat lines revealed elevated left ventricular pressure, improved systolic and diastolic parameters, attenuated negative force-frequency relation, and a dose-dependent beta-adrenergic effect. Aortic banding resulted in reduction of left ventricular pressure and worsening of contraction and relaxation parameters with no differences in mortality in both transgenic (+dP/dt 3084+/-96 vs. 3938+/-250 mmHg/s; RT(50) 47.0+/-1.2 vs. 36.7+/-1.4 ms) and wild-type rats (+dP/dt 2695+/-86 vs. 3297+/-122 mmHg/s; RT(50) 53.0+/-1.6 vs. 44.1+/-1.4). SERCA2a overexpressing hearts revealed improved hemodynamic parameters compared to wild-type controls. Acceleration of isovolumetric relaxation characterized by the index Tau was directly correlated to SERCA2a protein concentrations.
CONCLUSION: Overexpression of SERCA2a protein results in a positive inotropic effect under baseline conditions remaining preserved under pressure overload without affecting mortality. Therefore therapeutic transfer of SERCA2a may become a potential approach for gene therapy of congestive heart failure. Moreover, transgenic SERCA2a rats will be useful for studies of long-term SERCA2a overexpression in further cardiovascular disease models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909321     DOI: 10.1016/s0008-6363(03)00429-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  31 in total

1.  Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a.

Authors:  Ilka Pinz; Rong Tian; Darrell Belke; Eric Swanson; Wolfgang Dillmann; Joanne S Ingwall
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

Review 2.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

Review 3.  Altered intracellular Ca2+ handling in heart failure.

Authors:  Masafumi Yano; Yasuhiro Ikeda; Masunori Matsuzaki
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  [Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure].

Authors:  Klara Brixius; Konrad F Frank; Birgit Bölck; Felix Hoyer; Robert H G Schwinger
Journal:  Wien Med Wochenschr       Date:  2006-04

5.  Persistent overexpression of SERCA2a affects bladder functions under physiological conditions, but not in bladder outlet obstruction-induced sub-acute pathological conditions.

Authors:  Atsushi Yamada; Kazumasa Torimoto; Koji Obata; Akihide Hirayama; Kiyohide Fujimoto; Miyako Takaki
Journal:  J Physiol Sci       Date:  2013-09-14       Impact factor: 2.781

6.  Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis.

Authors:  Vittoria Carnicelli; Sabina Frascarelli; Sandra Ghelardoni; Simonetta Ronca-Testoni; Riccardo Zucchi
Journal:  Mol Cell Biochem       Date:  2008-03-26       Impact factor: 3.396

7.  Enhanced L-type calcium currents in cardiomyocytes from transgenic rats overexpressing SERCA2a.

Authors:  Andre Kamkin; Irina Kiseleva; Heinz Theres; Jaime-Jürgen Eulert-Grehn; Kay-Dietrich Wagner; Holger Scholz; Roland Vetter
Journal:  Exp Clin Cardiol       Date:  2010

8.  Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.

Authors:  David P Kao; Brian D Lowes; Edward M Gilbert; Wayne Minobe; L Elaine Epperson; Leslie K Meyer; Debra A Ferguson; Ann Kirkpatrick Volkman; Ronald Zolty; C Douglas Borg; Robert A Quaife; Michael R Bristow
Journal:  Circ Cardiovasc Genet       Date:  2015-01-30

Review 9.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

10.  Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.

Authors:  Fuzhong Qin; Deborah A Siwik; David R Pimentel; Robert J Morgan; Andreia Biolo; Vivian H Tu; Y James Kang; Richard A Cohen; Wilson S Colucci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.